Sequence-specific inhibition of small rna function

The present invention relates to the discovery of a method for inhibiting RNA silencing in a target sequence-specific manner. RNA silencing requires a set of conserved cellular factors to suppress expression of gene-encoded polypeptide. The invention provides compositions for sequence-specific inact...

Full description

Saved in:
Bibliographic Details
Main Authors GYORGY HUTVANGER, PHILLIP ZAMORE
Format Patent
LanguageEnglish
Published 01.06.2007
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to the discovery of a method for inhibiting RNA silencing in a target sequence-specific manner. RNA silencing requires a set of conserved cellular factors to suppress expression of gene-encoded polypeptide. The invention provides compositions for sequence-specific inactivation of the RISC component of the RNA silencing pathway, and methods of use thereof. The RISC inactivators of the present invention enable a variety of methods for identifying and characterizing miRNAs and siRNAs, RISC-associated factors, and agents capable of modulating RNA silencing. Therapeutic methods and compositions incorporating RISC inactivators and therapeutic agents identified through use of RISC inactivators are also featured.
Bibliography:Application Number: HK20070103743